phase 1_initiation
saveTerSera Therapeutics LLC — goserelin LA (Phase I Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Data sources
globaldata
Found something off?
drug timeline · 8
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalSep 23, 2025 · 382d ago
- approvalZOLADEX (GOSERELIN) — FDA approvalSep 23, 2025 · 382d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalSep 23, 2025 · 382d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalMar 16, 2023 · 1304d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalJun 17, 2021 · 1941d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalJun 17, 2021 · 1941d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalJul 19, 2016 · 3735d ago
- approvalZOLADEX (GOSERELIN ACETATE) — FDA approvalFeb 12, 2015 · 4258d ago
comments(0)
5-min edit window · permanent after that